1 min read

Veristat Joined the Battle to Fight Rare Cancers for the Tenth Year Running with Cycle for Survival 2024

We did it again! A Successful Cycle for Survival Ride Raising Over $90K To Support Rare Cancer Research

Cycle for Survival

Tenth year running - Team Veristat participated in Memorial Sloan Kettering's Cycle for Survival, the movement to beat rare cancers. Founded in partnership with Equinox fitness club seventeen years ago, this ground-breaking research fundraiser has raised over $369M for rare cancer research to date.

This year, Team Veristat raised over $90,000 and a fantastic total of over $870,000 in ten years! A big congratulations to our teams around the globe.



We Support Rare Disease Research – It’s What We Do Everyday

Veristat is so passionate about Cycle for Survival because 100% of the funds raised go directly to rare cancer research within six months. And that research doesn't only benefit MSK patients; it advances and lifts up the technology, and most importantly, the hope, for rare cancer patients everywhere. This aligns with Veristat’s key goal to bring rare cancer therapies to patients sooner!

Together, We Will Beat Rare Cancers

Veristat is raising money for Cycle for Survival, the movement to beat rare cancers. Will you donate to help us go above and beyond our fundraising goal?

Help our team by donating today to give people facing rare cancers hope for a better future. Around half of all people diagnosed with cancer have a rare form of the disease. Since 2007, the Cycle for Survival community has provided funding to hundreds of doctors and scientists in pursuit of bold ideas. From FDA approval of new drugs to the development of innovative diagnostic tools, Cycle for Survival–funded breakthroughs are transforming the way rare cancers are treated around the world.

Your support makes so much possible. Together we will continue to fight until every person with a rare cancer has a way to treat — or beat — their disease.

Donate Today > 

1 min read

Chief Medical Officer Summit -CMO 360°

Meet the Veristat team at Booth #3, April 17th and 18th in Boston

The Science-First CRO™ and Consultancy Ready to...

4 min read

Plenary Session Presentation: Putting Science First in Rare Disease Studies

Don´t miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Boston, Thursday, April 25th at...